Beacon Investment Advisory Services Inc. Reduces Stake in Intuitive Surgical, Inc. $ISRG

Posted by Francis Steltz on Aug 8th, 2026

Beacon Investment Advisory Services Inc. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 4.9% in the second quarter, Holdings Channel reports. The fund owned 36,626 shares of the medical equipment provider’s stock after selling 1,895 shares during the quarter. Beacon Investment Advisory Services Inc.’s holdings in Intuitive Surgical were worth $14,565,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Draper Asset Management LLC increased its holdings in Intuitive Surgical by 41.9% in the 4th quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock worth $2,848,000 after acquiring an additional 1,485 shares during the last quarter. Deutsche Bank AG boosted its position in Intuitive Surgical by 9.6% during the fourth quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider’s stock worth $862,108,000 after purchasing an additional 132,966 shares during the period. Oppenheimer Asset Management Inc. boosted its position in Intuitive Surgical by 29.3% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock worth $40,255,000 after purchasing an additional 16,119 shares during the period. KBC Group NV increased its stake in shares of Intuitive Surgical by 4.7% in the fourth quarter. KBC Group NV now owns 420,593 shares of the medical equipment provider’s stock worth $238,207,000 after purchasing an additional 18,697 shares in the last quarter. Finally, Dara Capital US Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $2,248,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president directly owned 5,720 shares in the company, valued at $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 6,634 shares of company stock valued at $2,796,795 in the last three months. 0.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. Mizuho set a $500.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Wednesday, July 15th. UBS Group assumed coverage on shares of Intuitive Surgical in a research note on Tuesday, July 28th. They issued a “neutral” rating and a $500.00 price objective for the company. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. BTIG Research dropped their target price on Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Finally, Bank of America cut their price target on Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Twenty equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $509.02.

Read Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Trading Up 1.4%

Intuitive Surgical stock opened at $378.81 on Friday. The firm’s 50 day simple moving average is $392.87 and its 200 day simple moving average is $445.78. The firm has a market capitalization of $133.83 billion, a PE ratio of 43.39, a price-to-earnings-growth ratio of 2.70 and a beta of 1.46. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period last year, the firm earned $1.81 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.